Drugs / bupivicain
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT05277974 Comparator | Feb → Jun 2022 | — | Sheikh Zayed Medical College | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | bupivicain | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05277974 ↗ |
| Route | Other | “30ml of inj. bupivicaine only will be given in Erector Spinae Plane Block” NCT05277974 ↗ |